GlassScriptPhysician profile
Paul E Wawrzynski
NPI 1861457897
$31,331.74
in general payments reported to CMS, 2019-2025
48 companies · $2,897 in 2025
The $2,897 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,708 · 2020: $3,489 · 2021: $5,453 · 2022: $5,483 · 2023: $4,527 · 2024: $4,774 · 2025: $2,897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $21.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,176.63 |
| Education | $21.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,770.59 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $2,766.72 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $2,500.24 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $2,401.49 | 2019-2025 | Farxiga, Lokelma |
| Novartis Pharmaceuticals Corporation | $2,278.88 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,800.39 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,634.44 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $1,548.85 | 2019-2025 | |
| Novo Nordisk INC | $1,436.79 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Amarin Pharma, INC. | $1,358.29 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,067.21 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $1,018.83 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $904.42 | 2019-2024 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $795.07 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Esperion Therapeutics, INC. | $746.74 | 2020-2025 | Nexletol |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $740.18 | 2019-2025 | Watchman Access System, Watchman, Watchman Flx |
| Scpharmaceuticals INC. | $637.52 | 2023-2025 | |
| Kowa Pharmaceuticals America, INC. | $547.93 | 2019-2021 | |
| Vifor Pharma, INC. | $379.78 | 2019-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $318.96 | 2021-2023 | Arcalyst |
| Impulse Dynamics (USA) INC. | $314.32 | 2021-2023 | Optimizer |
| Lexicon Pharmaceuticals, INC. | $257.80 | 2023-2024 | Inpefa |
| Atricure, INC. | $257.54 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| United Therapeutics Corporation | $224.01 | 2019-2025 | Tyvaso, Orenitram, Tyvaso |
| Cvrx, INC. | $221.97 | 2022-2024 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $220.86 | 2024 | Arcalyst |
| Azurity Pharmaceuticals, INC. | $215.61 | 2023-2025 | Edarbi, Edarbi |
| Edwards Lifesciences Corporation | $197.90 | 2023-2024 | Sapien 3 Ultra Resilia |
| Altathera Pharmaceuticals LLC | $195.86 | 2022-2025 | Sotalol Hydrochloride |
| Abbott Laboratories | $193.91 | 2022-2024 | Gallant, Mitraclip, Jot Dx |
| Alnylam Pharmaceuticals INC. | $170.94 | 2020-2025 | Onpattro |
| Tactile Systems Technology INC | $168.31 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Arbor Pharmaceuticals, INC. | $139.62 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $129.95 | 2019 | |
| Phathom Pharmaceuticals, INC. | $129.14 | 2024 | Voquezna |
| Lundbeck LLC | $118.16 | 2019-2021 | |
| Inspire Medical Systems, INC. | $113.41 | 2025 | Inspire |
| Genzyme Corporation | $78.21 | 2021 | |
| Gilead Sciences, INC. | $73.38 | 2019 | |
| Corcept Therapeutics | $57.85 | 2023 | Korlym |
| Abiomed | $43.59 | 2023 | Impella |
| Preventice Services, LLC | $27.37 | 2021 | |
| Daiichi Sankyo INC. | $26.74 | 2023 | Injectafer |
| Kestra Medical Technology Services, INC. | $24.42 | 2023 | Assure Wcd |
| Bridgebio Pharma, INC. | $20.50 | 2025 | Attruby |
| Ethicon INC. | $20.24 | 2025 | Monarch Platform |
| Heartflow, INC. | $19.49 | 2025 | |
| Amryt Pharma Holdings LTD | $17.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Wawrzynski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.